LANZINO, Marilena
 Distribuzione geografica
Continente #
NA - Nord America 4.318
EU - Europa 2.619
AS - Asia 1.088
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 14
SA - Sud America 14
Totale 8.179
Nazione #
US - Stati Uniti d'America 4.202
UA - Ucraina 1.006
DE - Germania 628
CN - Cina 462
AT - Austria 366
SG - Singapore 321
SE - Svezia 277
IT - Italia 152
TR - Turchia 133
CA - Canada 111
IN - India 106
SN - Senegal 106
FI - Finlandia 63
GB - Regno Unito 26
HK - Hong Kong 25
FR - Francia 22
CZ - Repubblica Ceca 19
KR - Corea 15
EU - Europa 14
NL - Olanda 14
AU - Australia 12
BE - Belgio 12
IR - Iran 8
BR - Brasile 6
EE - Estonia 5
ES - Italia 4
MX - Messico 4
PT - Portogallo 4
RU - Federazione Russa 4
AR - Argentina 3
EG - Egitto 3
AZ - Azerbaigian 2
EC - Ecuador 2
HU - Ungheria 2
IE - Irlanda 2
IL - Israele 2
JP - Giappone 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PE - Perù 2
PL - Polonia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
TN - Tunisia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 8.179
Città #
Chandler 662
Jacksonville 620
San Mateo 370
Boardman 331
Dearborn 318
Singapore 265
Vienna 240
New York 204
Ashburn 190
Roxbury 133
Lawrence 130
Izmir 124
Shanghai 117
Dakar 106
Des Moines 94
Ottawa 93
Grafing 79
Bremen 72
Beijing 66
Inglewood 64
Rende 63
Helsinki 62
Wilmington 45
Brooklyn 43
Ann Arbor 42
Ogden 41
Pune 36
Cambridge 34
Los Angeles 33
Guangzhou 26
Hong Kong 24
Seattle 20
Toronto 18
Wuhan 16
Seoul 15
Munich 13
San Francisco 13
Brussels 12
Florence 12
Jinan 12
Leawood 12
Redwood City 12
Houston 11
Olomouc 11
Augusta 10
Hanover 10
Bangalore 9
Monmouth Junction 9
Nanjing 9
Ningbo 9
Brno 8
Jinhua 8
Amsterdam 7
Cosenza 7
London 7
Melbourne 7
Shenzhen 7
Ardabil 6
Falls Church 6
Hefei 6
Nanchang 6
Norwalk 6
Wuxi 6
Berlin 5
Haikou 5
Jiaxing 5
Kunming 5
Latina 5
Santa Clara 5
Tallinn 5
Woodbridge 5
Zhengzhou 5
Buffalo 4
Kilburn 4
Lamezia Terme 4
Quanzhou 4
Belvedere Marittimo 3
Buenos Aires 3
Cairo 3
Canberra 3
Castrolibero 3
Frankfurt am Main 3
Hangzhou 3
Strasbourg 3
Taizhou 3
Yiwu 3
Auckland 2
Bagnara Calabra 2
Baku 2
Bratislava 2
Castrovillari 2
Chengdu 2
Chennai 2
Colombo 2
Costa Mesa 2
Dongyang 2
Hebei 2
Heze 2
Kocaeli 2
Lanzhou 2
Totale 5.166
Nome #
Akt2 inhibition enables the forkhead transcription factor FoxO3 to a repressive role for ERalpha transcriptional activity in breast cancer cells 115
1alpha,25- dihydroxyvitamin D3 receptor (VDR) in human sperm: its possible functional role. 108
Androgens inhibit aromatase expression through DAX-1: disclosing the molecular link between hormone balance and leydig cancer development. 106
Aromatase Inhibitor Resistance in Breast Cancer: a Potential Role for Cytokine Signaling Network 100
Bergapten affects cell survival and induces apoptosis in human breast cancer cells. 100
Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy 100
Androgen receptor activation inhibits the genomic effect of estradiol in MCF7 cells, a molecular basis of its antiproliferatie action 99
Bergapten antagonizes cell survival and induces p53 gene promoter together with p38 MAPK activation in breast cancer cells 98
Androgen Receptor (AR) Inhibits Cyclin D1 Promoter Activity. May AR be Considered as na Oncosuppressor in Breast Cancer? 97
Androgen receptor regulation of the cyclin D1 gene through an androgen response element in the proximal promoter 97
Akt inhibition enables the Forkhead Factor Foxo3a to a repressive role for ER alpha transcriptional activity in breast cancer cells 97
17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells 97
DAX-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogendependent breast cancer cell proliferation 92
Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development 92
A novel functional interplay between Progesterone Receptor-B and PTEN, via AKT, modulates autophagy in breast cancer cells 92
Androgen role in breast cancer. 91
AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells 89
Progesterone Receptor B signaling Reduces Breast Cancer Cell Aggressiveness: Role of Cyclin-D1/Cdk4 Mediating Paxillin Phosphorylation 88
A time course study on the "in vitro" effect of T3 and Testosterone on androgen and estrogen receptors in peripuberal rat Sertoli cells. 86
Antiproliferative and autophagic effects of omega-3 EPA and DHA-dopamine conjugates in human breast cancer cells. 85
Aromatase expression in prepuberal Sertoli cells: effects of thyroid hormone 84
Aromatase expression in prepuberal Sertoli cells: Effect of thyroid hormone 84
Effect of T3 on aromatase and estrogen receptor contents in peripuberal Sertoli cells 83
ARA70 interagisce con il recettore estrogenico e modula il cross-talk funzionale tra recettore estrogenico e recettore androgenico in cellule MCF-7 83
Androgen receptor activation inhibits the genomic effect of estradiol in MCF-7 cells. A molecular basis of its antiproliferative action 80
Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells 80
AR/ER coactivator squelcing contributes to the inhibition of estrogen-dependent cyclin D1 expression in breast cancer 78
Ultrastructural localization of cannabinoid 1 receptor (CB1-R) in humane male gamete and a potential role of anandamide in male fertility. 78
A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells 78
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 78
Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis 78
Androgen metabolism and estrogen receptor content in peripuberal Sertoli cells in hypothyroid rats 78
Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy 75
ARA 70 associates with estrogen receptor and modulates its transcriptional activity in breast cancer cell line MCF-7 75
A novel interplay between AR and DAX-1 controls aromatase expression in estrogen-dependent cancers 74
Androgen receptor downregulates estrogen receptor signal in MCF-7 breast cancer cells 74
Different Biological Effects of Chenodeoxycholic acid (CDCA) in Endometrial Cancer 74
Update on human sperm anatomy: new perspectives in the treatment of human male fertility 73
Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor α transcriptional activity in breast cancer cells 73
Effect of triiodothyronine administration on estrogen receptor contents in peripuberal Sertoli cells 72
DAX-1 at the Crossroads Between Androgens and Aromatase: A Novel Mechanism in the Inhibition of Estrogen-Dependent Cancer Cell Proliferation 71
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 71
Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor 70
Human sperm express a functional androgen receptor: effects on PI3K/Akt pathway 69
Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression 69
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity 68
Androgen receptor (AR) inhibits cyclin D1 promoter activity. May AR be considered as an oncosuppressor in breast cancer? 68
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 68
Aromatase messenger RNA is derived from the proximal promoter of the aromatase gene in Leydig, Sertoli, and Germ cells of the rat testis 68
Follow-up study of thyroid function in polytransfused thalassemic patients 67
Different Biological Effects of Chenodeoxycholic acid (CDCA)in Endometrial Cancer 67
ARA70 associates with estrogen and modulates its transcriptional activity in breast cancer cell line MCF-7 67
FoxO3a mediates the inhibitory effects of the antiepileptic drug Lamotrigine on breast cancer growth 67
Aromatase expression in peripuberal Sertoli cells:: effect of thyroid hormone 67
Loss of proline-rich tyrosine kinase 2 function induces spreading and motility of epithelial prostate cells 66
Role of IRS-1 signaling in insulin- induced modulation of estrogen receptors in breast cancer cells 66
Breast cancer: from estrogen to androgen receptor 66
Chenodeoxycholic acid through a TGR5-dependent CREB-signaling activation enhances Cyclin D1 expression and promotes human endometrial cancer cell proliferation 66
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 65
Endogenous coactivator ARA70 interacts with estrogen receptor alpha (ERalpha) and modulates the functional ERalpha/androgen receptor interplay in MCF-7 cells 61
Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer 60
Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation 60
Effects of triiodothyronine (T3) on alternative splicing events in the coding region of P450 aromatase in immature Sertoli cells. 60
Effect of T3 on aromatase and estrogen receptor content in peripuberal Sertoli cells 60
A role for the anandamide in human sperm survival 59
Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element 59
Proliferative activity ER and PR contents in two hormone dipendent and indipendent MCF-7 cell lines: influence of estradiol and insulin. 59
GH secretion in thalassemia patients with short stature. 58
Up-regulatory effects of androgens on estrogen receptor in MCF-7 breast cancer cells 58
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth 58
Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells. 56
Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells 55
Human sperm molecular anatomy: the enzyme 5α-reductase (SRD5A) is present in the sperm and may be involved in the varicocele-related infertility. 55
Fas ligand in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction with Sp-1 53
Valutazione della secrezione dell'ormone della crescita (GH) dopo somministrazione di GHRH e PD-GHRH in soggetti affetti da Thalassemia Major con bassa statura 53
Effects of tri-iodothyronine on alternative splicing events in the coding region of cytochrome P450 aromatase in immature rat Sertoli cells 53
Influence of somatostatin tone on the GH secretion in thalassemic patients with short stature. 53
Nutraceuticals in the mediterranean diet: Potential avenues for breast cancer treatment 53
Follo-up study on the effects of thyroid hormone administration on androgen metabolism of peripubertal rat Sertoli cells 52
Influence of thyroid hormone on androgen metabolism, AR and ER contents in peripuberal Sertoli cells. 51
Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets 51
Thyroid hormone modulates androgen and estrogen receptor content in the Sertoli cells of peripuberal rats 50
Farnesoid X receptor, through the binding with steroidogenic factor 1 responsive element, inhibits aromatase expression in tumor leydig cells 50
Update on human sperm anatomy:new perspectives in the treatment of human male fertilità 50
Phosphodiesterase type 5 promotes the invasive potential of breast cancer cells through Rho GTPase activation. 50
Proliferative activity, ER and PR contents in two hormone dependent and independent MCF-7 cell lines: influence of estradiol and insulin 49
Funzione tiroidea e metabolismo androgenico nelle cellule del Sertoli. 49
Nandrolone and Stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation 49
Estrogen receptor content in peripuberal rat Sertoli cells: effect of thyroid hormone administration 48
Fas ligand expression in TM4 sertoli cells is enhanced by estradiol "in situ" production 48
Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells 48
Endogenously expressed coactivator ARA 70 interacts with ERalpha and modulates the functional interaction between ERalpha and AR in MCF-7 breast cancer cells 48
Expression and Function of Androgen Receptor in Human Breast Cancer-Associated Fibroblasts: May Androgens Shape Breast Tumor Microenvironment? 48
Inhibition of Leydig tumor growth by Farnesoid X Receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy 48
Update on human sperm anatomy:new perspectives in the treatment of human male infertility 47
Triiodothyronine influences dbcAMP stimulated expression of estrogen receptor and aromatase in Sertoli cells 47
Influence of thyroid hormone on androgen metabolism in peripuberal rat Sertoli cells 46
Effects of triiodothyronine (T3) on alternative splicing events in the coding region of P450 aromatase in immature rat Sertoli cells. 46
Red wine consumption may affect sperm biology: The effects of different concentrations of the phytoestrogen Myricetin on human male gamete function 46
Foxo3a inhibits tamoxifen-resistant breast cancer progression by inducing integrin α5 expression 46
Totale 6.917
Categoria #
all - tutte 55.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020921 0 0 0 0 76 324 100 156 33 17 135 80
2020/20211.117 147 7 127 137 6 137 10 133 112 133 53 115
2021/20221.680 24 242 10 104 195 87 12 393 10 14 224 365
2022/20231.722 248 224 64 196 289 129 16 174 189 50 67 76
2023/20241.211 131 43 70 45 58 353 47 54 101 38 35 236
2024/2025857 186 332 110 137 92 0 0 0 0 0 0 0
Totale 8.313